Month: March 2021

2024.07.17
Summary of the most important events and achievements of the Genomtec S.A.

2024.06.25
Webinar: Trends in the M&A Market Specific to In-Vitro Diagnostics | 27 June, 2024, 3:00 p.m. (CEST)

2024.04.22
Dr. Trevor Hawkins, a distinguished entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Genomtec S.A.

2024.03.26
Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project - Company will raise capital from founding shareholders and investors

2024.03.26
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

Archive

2021.03.18

Genomtec diagnostic test SARS-CoV-2 Duo Kit (cat. no. GA00B) detects newly identified Breton Variant in France

Company has recently confirmed diagnostic positive performance of its most advanced product, Genomtec® SARS-CoV-2 EvaGreen® RT-LAMP CE-IVD Duo ...
Read

Archive